MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Proteus ⇒ Erysipelatoclostridium {10000255}

Record Keys
Parent:
Definition:
Erysipelatoclostridium

Details
Initialisation date:
2020-09-30

Meta Information
Rank:
 Species
Domain:
 Bacteria
Enzyme:[  ]
Function:[  ]

Notes:

[  ]

Shared Reference Notes

  • [1.1] 
    - Maternal exposure to #Fructose > reduces the abundance of Erysipelatoclostridium in the infant gut microbiome.
  • [1.2] [#Alzheimer’s disease] 
    - #Treatment with Rifamixin > significant reduction in serum neurofilament-light levels >significant increase in fecal phylum Firmicutes microbiota. #Treatment with Rifamixin > reduces Serum pTau181 and GFAP levels and non-significant downward trend in serum cytokine IL-6 and IL-13 levels. Increases in stool Erysipelatoclostridium > correlated significantly with reductions in serum pTau 181 and serum GFAP.
  • [1.3] 
    - Higher caffeine and #Coffee intake was related to higher alpha diversity higher relative abundance of #Faecalibacterium and #Alistipes, and lower relative abundance of Erysipelatoclostridium. - After adjustment of vitamin B2 in multivariate analysis, the significant inverse association between Erysipelatoclostridium count and caffeine intake remained statistically significant.

References Notes

[  ]